Structure-based Design of Conformationally Flexible Reverse Transcriptase Inhibitors to Combat Resistant HIV

E-ISSN： 1873-4286|20|5|725-739

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.5, 2014-02, pp. : 725-739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite

Computer-Aided Perspective for the Design of Flexible HIV Non- Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): de-novo Drug Design, Virtual Screening and Molecular Dynamics Simulations

Letters in Drug Design & Discovery, Vol. 11, Iss. 4, 2014-05 ,pp. : 513-524

Bentham Science Publishers

Access to resources Recommend Favorite

Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase: from the Biology of Reverse Transcription to Molecular Design

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 13, 2003-09 ,pp. : 1496-1511

Bentham Science Publishers

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite